Toxicity of quantum dots on respiratory system

Inhalation Toxicology

Volumn 26, Issue 2, 2014, Pages 128-139

  Wu, Tianshu ^a,b   Tang, Meng ^a,b  

^a SOUTHEAST UNIVERSITY   (China)

^b Southeast University   (China)

Author keywords

Nanotoxicology; Quantum dot; Respiratory system

Indexed keywords

QUANTUM DOT;

AEROSOL; BIOCOMPATIBILITY; CELL VIABILITY; COMPARATIVE STUDY; DRUG DELIVERY SYSTEM; ENVIRONMENTAL EXPOSURE; GENETIC DAMAGE; HUMAN; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG INJURY; LUNG PARENCHYMA; NANOTECHNOLOGY; NANOTOXICOLOGY; OCCUPATIONAL SAFETY; PHYSICAL CHEMISTRY; PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESPIRATORY SYSTEM; REVIEW;

HUMANS; INFLAMMATION; LUNG DISEASES; LUNG INJURY; QUANTUM DOTS; RESPIRATORY SYSTEM;

EID: 84893528110     PISSN: 08958378     EISSN: 10917691     Source Type: Journal    
DOI: 10.3109/08958378.2013.871762     Document Type: Review

References (79)

1. Aboulaich A, Tilmaciu CM, Merlin C, et al. (2012). Physicochemical properties and cellular toxicity of (poly)aminoalkoxysilanesfunctionalized ZnO quantum dots. Nanotechnology 23:335101. doi: 10.1088/0957-4484/23/33/335101.
2. Akhter S, Ahmad I, Ahmad MZ, et al. (2013). Nanomedicines as cancer therapeutics: current status. Curr Cancer Drug Targets 13: 362-78.
3. Azzazy HM, Mansour MM, Kazmierczak SC. (2007). From diagnostics to therapy: prospects of quantum dots. Clin Biochem 40: 917-27.
4. Bonner JC. (2011). Carbon nanotubes as delivery systems for respiratory disease: do the dangers outweigh the potential benefits? Exp Rev Respir Med 5:779-87.
5. Bradburne CE, Delehanty JB, Boeneman Gemmill K, et al. (2013). Cytotoxicity of quantum dots used for in vitro cellular labeling: role of QD surface ligand, delivery modality, cell type, and direct comparison to organic fluorophores. Bioconjug Chem 24:1570-83.
6. Bruneau A, Fortier M, Gagne F, et al. (2013). In vitro immunotoxicology of quantum dots and comparison with dissolved cadmium and tellurium. Environ Toxicol [Epub ahead of print]. doi: 10.1002/ tox.21890.
7. Brunetti V, Chibli H, Fiammengo R, et al. (2013). InP/ZnS as a safer alternative to CdSe/ZnS core/shell quantum dots: in vitro and in vivo toxicity assessment. Nanoscale 5:307-17.
8. Buzea C, Pacheco II, Robbie K. (2007). Nanomaterials and nanoparticles: sources and toxicity. Biointerphases 2:MR17-71.
9. Chen Z, Chen H, Meng H, et al. (2008). Bio-distribution and metabolic paths of silica coated CdSeS quantum dots. Toxicol Appl Pharmacol 230:364-71.
10. Choi HS, Liu W, Misra P, et al. (2007). Renal clearance of quantum dots. Nat Biotechnol 25:1165-70.
11. Choi YJ, Kim YJ, Lee JW, et al. (2012). Cyto-/genotoxic effect of CdSe/ ZnS quantum dots in human lung adenocarcinoma cells for potential photodynamic UV therapy applications. J Nanosci Nanotechnol 12: 2160-8.
12. Costa-Fern Ndez JM, Pereiro R, Sanz-Medel A. (2006). The use of luminescent quantum dots for optical sensing. Trends Analyt Chem 25:207-18.
13. Dobrovolskaia MA, McNeil SE. (2007). Immunological properties of engineered nanomaterials. Nat Nanotechnol 2:469-78.
14. Erogbogbo F, Yong K-T, Roy I, et al. (2008). Biocompatible luminescent silicon quantum dots for imaging of cancer cells. Acs Nano 2: 873-8.
15. Fischer HC, Liu L, Pang KS, Chan WC. (2006). Pharmacokinetics of nanoscale quantum dots: in vivo distribution, sequestration, and clearance in the rat. Adv Funct Mater 16:1299-305.
16. Gagne F, Fortier M, Yu L, et al. (2010). Immunocompetence and alterations in hepatic gene expression in rainbow trout exposed to CdS/CdTe quantum dots. J Environ Monit 12:1556-65.
17. Gao X, Cui Y, Levenson RM, et al. (2004). In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 22: 969-76.
18. Gessler T. (2009). Inhalative pharmacotherapy in the future - nanocarriers for pulmonary drug delivery. Pneumologie 63:S113-16.
19. Hardman R. (2006). A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors. Environ Health Perspect 114:165-72.
20. Hines MA, Guyot-Sionnest P. (1996). Synthesis and characterization of strongly luminescing ZnS-capped CdSe nanocrystals. J Phys Chem 100:468-71.
21. Ho CC, Chang H, Tsai HT, et al. (2013). Quantum dot 705, a cadmium-based nanoparticle, induces persistent inflammation and granuloma formation in the mouse lung. Nanotoxicology 7: 105-15.
22. Hohng S, Ha T. (2005). Single-molecule quantum-dot fluorescence resonance energy transfer. ChemPhysChem 6:956-60.
23. Hoshino A, Hanada S, Manabe N, et al. (2009). Immune response induced by fluorescent nanocrystal quantum dots in vitro in vivo. IEEE Trans NanoBiosci 8:51-7.
24. Hoshino A, Hanada S, Yamamoto K. (2011). Toxicity of nanocrystal quantum dots: the relevance of surface modifications. Archiv Toxicol 85:707-20.
25. Hyun B-R, Chen H, Rey DA, et al. (2007). Near-infrared fluorescence imaging with water-soluble lead salt quantum dots. J Phys Chem B 111:5726-30.
26. IARC. (2013). Agents classified by the IARC monographs. Vol. 1-108 [Online]. Available from: http://monographs.iarc.fr/ENG/ Classification/ ClassificationsGroupOrder.pdf [Last accessed: 22 Aug 2013].
27. Jacobsen NR, Moller P, Jensen KA, et al. (2009). Lung inflammation and genotoxicity following pulmonary exposure to nanoparticles in ApoE-/- mice. Part Fibre Toxicol 6:2. doi: 10.1186/1743-8977-6-2.
28. Jaiswal JK, Mattoussi H, Mauro JM, Simon SM. (2002). Long-term multiple color imaging of live cells using quantum dot bioconjugates. Nat Biotechnol 21:47-51.
29. Jamieson T, Bakhshi R, Petrova D, et al. (2007). Biological applications of quantum dots. Biomaterials 28:4717-32.
30. Ju L, Zhang G, Zhang C, et al. (2013). Quantum dot-related genotoxicity perturbation can be attenuated by PEG encapsulation. Mutat Res 753: 54-64.
31. Juzenas P, Chen W, Sun Y-P, et al. (2008). Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer. Adv Drug Deliv Rev 60:1600-14.
32. Kairdolf BA, Smith AM, Stokes TD, et al. (2013). Semiconductor quantum dots for bioimaging and biodiagnostic applications. Annu Rev Analyt Chem 6:143-62.
33. King-Heiden TC, Wiecinski PN, Mangham AN, et al. (2009). Quantum dot nanotoxicity assessment using the zebrafish embryo. Environ Sci Technol 43:1605-11.
34. Leutwyler WK, B Rgi SL, Burgl H. (1996). Semiconductor clusters, nanocrystals, and quantum dots. Science 271:933-7.
35. Li K, Chen J, Bai S, et al. (2009). Intracellular oxidative stress and cadmium ions release induce cytotoxicity of unmodified cadmium sulfide quantum dots. Toxicol In Vitro 23:1007-13.
36. Li Z, Ruckenstein E. (2004). Water-soluble poly (acrylic acid) grafted luminescent silicon nanoparticles and their use as fluorescent biological staining labels. Nano Lett 4:1463-7.
37. Lin P, Chen J-W, Chang LW, et al. (2008). Computational and ultrastructural toxicology of a nanoparticle, Quantum Dot 705, in mice. Environ Sci Technol 42:6264-70.
38. Liu J, Erogbogbo F, Yong K-T, et al. (2013a). Assessing clinical prospects of silicon quantum dots: studies in mice and monkeys. ACS Nano 7:7303-10.
39. Liu X, Tang M, Zhang T, et al. (2013b). Determination of a threshold dose to reduce or eliminate CdTe-induced toxicity in L929 cells by controlling the exposure dose. PloS One 8:e59359.
40. LovrićJ, Bazzi HS, Cuie Y, et al. (2005). Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots. J Mol Med 83:377-85.
41. Luo Y-H, Wu S-B, Wei Y-H, et al. (2013). Cadmium-based quantum dot induced autophagy formation for cell survival via oxidative stress. Chem Res Toxicol 26:662-73.
42. Ma?nsson A, Sundberg M, Balaz M, et al. (2004). In vitro sliding of actin filaments labelled with single quantum dots. Biochem Biophys Res Commun 314:529-34.
43. Ma-Hock L, Brill S, Wohlleben W, et al. (2012). Short term inhalation toxicity of a liquid aerosol of CdS/Cd(OH)(2) core shell quantum dots in male Wistar rats. Toxicol Lett 208:115-24.
44. Mattoussi H, Palui G, Na HB. (2012). Luminescent quantum dots as platforms for probing in vitro and in vivo biological processes. Adv Drug Deliv Rev 64:138-66.
45. McConnachie LA, Botta D, White CC, et al. (2013). The glutathione synthesis gene gclm modulates amphiphilic polymer-coated CdSe/ZnS quantum dot-induced lung inflammation in mice. PloS One 8:e64165.
46. Medintz IL, Uyeda HT, Goldman ER, Mattoussi H. (2005). Quantum dot bioconjugates for imaging, labelling and sensing. Nat Mater 4: 435-46.
47. Michalet X, Pinaud F, Bentolila L, et al. (2005). Quantum dots for live cells, in vivo imaging, and diagnostics. Science 307:538-44.
48. Nagy A, Steinbruück A, Gao J, et al. (2012). Comprehensive Analysis of the effects of CdSe quantum dot size, surface charge, and functionalization on primary human lung cells. ACS Nano 6: 4748-62.
49. Nguyen KC, Seligy VL, Tayabali AF. (2013a). Cadmium telluride quantum dot nanoparticle cytotoxicity and effects on model immune responses to Pseudomonas aeruginosa. Nanotoxicology 7: 202-11.
50. Nguyen KC, Willmore WG, Tayabali AF. (2013b). Cadmium telluride quantum dots cause oxidative stress leading to extrinsic and intrinsic apoptosis in hepatocellular carcinoma HepG2 cells. Toxicology 306: 114-23.
51. NIOSH. (2009). Strategic plan for NIOSH nanotechnology research and guidance: filling the knowledge gaps. [Online]. Available from: http:// www.cdc.gov/niosh/docs/2010-105/pdfs/2010-105.pdf [Last accessed: 22 Aug 2013].
52. Nurunnabi M, Khatun Z, Huh KM, et al. (2013). In vivo biodistribution and toxicology of carboxylated graphene quantum dots. ACS Nano 7:6858-67.
53. Pelley JL, Daar AS, Saner MA. (2009). State of academic knowledge on toxicity and biological fate of quantum dots. Toxicol Sci 112: 276-96.
54. Prasad PN. (2004). Introduction to biophotonics. Hoboken (NJ): John Wiley & Sons.
55. Qian H, Dong C, Peng J, et al. (2007). High-quality and watersoluble near-infrared photoluminescent CdHgTe/CdS quantum dots prepared by adjusting size and composition. J Phys Chem C 111: 16852-7.
56. Ramot Y, Steiner M, Morad V, et al. (2010). Pulmonary thrombosis in the mouse following intravenous administration of quantum dotlabeled mesenchymal cells. Nanotoxicology 4:98-105.
57. Roberts JR, Antonini JM, Porter DW, et al. (2013). Lung toxicity and biodistribution of Cd/Se-ZnS quantum dots with different surface functional groups after pulmonary exposure in rats. Particle Fibre Toxicol 10:5. doi: 10.1186/1743-8977-10-5.
58. Rzigalinski BA, Strobl JS. (2009). Cadmium-containing nanoparticles: perspectives on pharmacology and toxicology of quantum dots. Toxicol Appl Pharmacol 238:280-8.
59. Sadaf A, Zeshan B, Wang Z, et al. (2012). Toxicity evaluation of hydrophilic CdTe quantum dots and CdTe@SiO2 nanoparticles in mice. J Nanosci Nanotechnol 12:8287-92.
60. Santra S, Yang H, Stanley JT, et al. (2005). Rapid and effective labeling of brain tissue using TAT-conjugated CdS: Mn/ZnS quantum dots. Chem Commun 25:3144-6.
61. Shao L, Gao Y, Yan F. (2011). Semiconductor quantum dots for biomedicial applications. Sensors 11:11736-51.
62. Smith AM, Duan H, Mohs AM, Nie S. (2008). Bioconjugated quantum dots for in vivo molecular and cellular imaging. Adv Drug Deliv Rev 60:1226-40.
63. Tang S, Cai Q, Chibli H, et al. (2013a). Cadmium sulfate and CdTe-quantum dots alter DNA repair in zebrafish (Danio rerio) liver cells. Toxicol Appl Pharmacol 272:443-52.
64. Tang Y, Han S, Liu H, et al. (2013b). The role of surface chemistry in determining in vivo biodistribution and toxicity of CdSe/ZnS core-shell quantum dots. Biomaterials 34:8741-55.
65. Tsoi KM, Dai Q, Alman BA, Chan WC. (2012). Are quantum dots toxič Exploring the discrepancy between cell culture and animal studies. Acc Chem Res 46:662-71.
66. Wang S, Mamedova N, Kotov NA, et al. (2002). Antigen/antibody immunocomplex from CdTe nanoparticle bioconjugates. Nano Lett 2: 817-22.
67. Xu S, Ziegler J, Nann T. (2008). Rapid synthesis of highly luminescent InP and InP/ZnS nanocrystals. J Mater Chem 18:2653-6.
68. Xu ZQ, Lai L, Li DW, et al. (2013). Toxicity of CdTe QDs with different sizes targeted to HSA investigated by two electrochemical methods. Mol Biol Rep 40:1009-19.
69. Yang RS, Chang LW, Wu J-P, et al. (2007). Persistent tissue kinetics and redistribution of nanoparticles, quantum dot 705, in mice: ICP-MS quantitative assessment. Environ Health Perspect 115:1339-43.
70. Yang Y, Lan J, Xu Z, et al. (2013). Toxicity and biodistribution of aqueous synthesized ZnS and ZnO quantum dots in mice. Nanotoxicology 8:107-16.
71. Yong K-T. (2009). Mn-doped near-infrared quantum dots as multimodal targeted probes for pancreatic cancer imaging. Nanotechnology 20: 015102.
72. Yong K-T, Law W-C, Hu R, et al. (2013). Nanotoxicity assessment of quantum dots: from cellular to primate studies. Chem Soc Rev 42: 1236-50.
73. Yong KT, Roy I, Ding H, et al. (2009). Biocompatible near-infrared quantum dots as ultrasensitive probes for long-term in vivo imaging applications. Small 5:1997-2004.
74. Yong K-T, Roy I, Hu R, et al. (2010). Synthesis of ternary CuInS2/ZnS quantum dot bioconjugates and their applications for targeted cancer bioimaging. Integr Biol 2: 121-9.
75. Yong K-T, Wang Y, Roy I, et al. (2012). Preparation of quantum dot/drug nanoparticle formulations for traceable targeted delivery and therapy. Theranostics 2:681-94.
76. Theranostics 2:681-94. Zhang T, Stilwell JL, Gerion D, et al. (2006a). Cellular effect of high doses of silica-coated quantum dot profiled with high throughput gene expression analysis and high content cellomics measurements. Nano Lett 6:800-8.
77. Zhang Y, He J, Wang P-N, et al. (2006b). Time-dependent photoluminescence blue shift of the quantum dots in living cells: effect of oxidation by singlet oxygen. J Am Chem Soc 128:13396-401.
78. Zhang Y, Zhang Y, Hong G, et al. (2013). Biodistribution, pharmacokinetics and toxicology of Ag2S near-infrared quantum dots in mice. Biomaterials 34:3639-46.
79. Zheng H, Mortensen LJ, Delouise LA. (2013). Thiol antioxidantfunctionalized CdSe/ZnS quantum dots: synthesis, characterization, cytotoxicity. J Biomed Nanotechnol 9:382-92.